Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308295 · ClinicalTrials.gov registry record · NA
A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00308295: Completed NA study, sponsored by Indiana University.
NCT00308295 is a NA study that has completed, run by Indiana University. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308295, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.
Interventions
- DRUG Fish oil capsules
- DRUG matched placebo capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2006-04 |
| Est. Completion | 2006-05 |
| Phase | NA |
What the finished NCT00308295 record still lists
NCT00308295 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Fish oil capsules is the first listed.
NCT00308295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00308295 about?
NCT00308295 is a clinical study titled "A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients". The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.
What is the current status of trial NCT00308295?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2006-04. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00308295?
The interventions under investigation include: Fish oil capsules (DRUG), matched placebo capsules (DRUG).
Who is sponsoring clinical trial NCT00308295?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00308295's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia